benzoxazoles has been researched along with Anemia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ando, Y; Ikeda, T; Masuda, T; Misumi, Y; Shinriki, S; Ueda, M; Yamashita, T | 1 |
| Campbell, AD; Eitzman, DT; Guo, C; Harro, D; Tran, J; Wang, H; Wang, J | 1 |
2 other study(ies) available for benzoxazoles and Anemia
| Article | Year |
|---|---|
Unwanted road to anaemia in transthyretin familial amyloid polyneuropathy may continue irrespective of tafamidis treatment.
Topics: Amyloid Neuropathies, Familial; Anemia; Benzoxazoles; Blood Chemical Analysis; Disease Progression; Female; Humans; Longitudinal Studies; Male; Middle Aged; Retrospective Studies | 2018 |
mTOR Inhibition improves anaemia and reduces organ damage in a murine model of sickle cell disease.
Topics: Anemia; Anemia, Sickle Cell; Animals; Benzoxazoles; Disease Models, Animal; Erythrocytes; Hematocrit; Hemoglobins; Mice; Pyrimidines; Sirolimus; Splenomegaly; TOR Serine-Threonine Kinases | 2016 |